DrAnna Singleton

PhD, MSc (experimental Psych, thesis-based), BSc (Hons 1 Psych)

Dr Anna Singleton (she/her) is an NHMRC Emerging Leadership Fellow and Senior Research Fellow at the Daffodil Centre, a Flagship Centre of the Faculty of Medicine and Health, University of Sydney and partnership with Cancer Council NSW. Anna has a background in psychology (PhD Dec 2021, MSc Experimental Psych; BSc Hons I Psych) and her research aims to co-design and implement scalable and accessible digital health strategies to improve health outcomes for people living with and beyond cancer. Anna has been awarded >$5.9M in research funds and awards (>$2.3M as CIA/B) and published >40 peer-reviewed manuscripts, including high-impact journals like theJournal of Clinical Oncology (IF 45.3).Anna was awarded the 2025 International Psychosocial Oncology Society Hiroomi & Setsuko Kawano New Investigator Award for outstanding early career researcher in psycho-oncology, the 2023 NSW Premier's Award for Outstanding Early Career Researcher and was named a top 25 Brilliant Woman in Digital Health in Australia by TelstraHeath (2022). The same year, Anna's EMPOWER-SMS clinical trial won the Consumer Involvement Award at the Australian Clinical Trials Alliance Trial of the Year Awards. This trial found that a health and wellness support program delivered via text messages was acceptable, useful and engaging for breast cancer survivors. Anna is now expanding this work by leading a national multi-centre trial in primary care to help more people across Australia. Anna also holds many leadership positions, including the Primary Care Collaborative Cancer Clinical Trials group Living with and Beyond Cancer Engine Room (2022-2025 co-chair + scientific advisory committee, 2026-member) and Topic Editor of Frontiers in Digital Health.